Gilde Healthcare amasses €600m for sixth venture fund

Gilde Healthcare Venture&Growth VI's limited partners include corporate institutions, banks, pension funds, insurers, fund-of-funds, sovereign wealth funds, endowments, family offices and entrepreneurs.

  • The fund focuses on growing companies active in digital health, medtech and therapeutics based in Europe and North America
  • It will invest €10m to €60m per new portfolio company
  • The specialized healthcare investor manages more than €2.5bn across venture/growth and private equity 

Gilde Healthcare has raised €600 million for its sixth venture fund.

Gilde Healthcare Venture & Growth VI’s limited partners include corporate institutions, banks, pension funds, insurers, fund-of-funds, sovereign wealth funds, endowments, family offices and entrepreneurs.

The fund focuses on growing companies active in digital health, medtech and therapeutics, based in Europe and North America.

“We are pleased with the strong interest from investors who support our mission,” managing partner Pieter van der Meer said in a statement. “Innovations that improve the quality of care but also keep it affordable are essential to ensure access to healthcare.”

The new fund will invest €10 million to €60 million per new portfolio company.

Headquartered in Utrecht, the Netherlands, Gilde Healthcare is a specialized healthcare investor that manages more than €2.5 billion across two fund strategies: venture/growth and private equity.